These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 10637277)

  • 21. CD4 and CD8 accessory molecules function through interactions with major histocompatibility complex molecules which are not directly associated with the T cell receptor-antigen complex.
    Lustgarten J; Waks T; Eshhar Z
    Eur J Immunol; 1991 Oct; 21(10):2507-15. PubMed ID: 1915555
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The mode of ligand recognition by two peptide:MHC class I-specific monoclonal antibodies.
    Messaoudi I; LeMaoult J; Nikolić-Zugić J
    J Immunol; 1999 Sep; 163(6):3286-94. PubMed ID: 10477598
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Coreceptor function of CD4 in response to MHC class I molecule].
    Zvezdova ES; Grinenko TS; Pobezinskaia EL; Pobezinskiĭ LA; Kazanskiĭ DB
    Mol Biol (Mosk); 2008; 42(4):662-72. PubMed ID: 18856067
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decreased binding of peptides-MHC class I (pMHC) multimeric complexes to CD8 affects their binding avidity for the TCR but does not significantly impact on pMHC/TCR dissociation rate.
    Dutoit V; Guillaume P; Ayyoub M; Hesdorffer CS; Luescher IF; Valmori D
    J Immunol; 2003 May; 170(10):5110-7. PubMed ID: 12734357
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Force-Regulated In Situ TCR-Peptide-Bound MHC Class II Kinetics Determine Functions of CD4+ T Cells.
    Hong J; Persaud SP; Horvath S; Allen PM; Evavold BD; Zhu C
    J Immunol; 2015 Oct; 195(8):3557-64. PubMed ID: 26336148
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lack of strict correlation of functional sensitization with the apparent affinity of MHC/peptide complexes for the TCR.
    al-Ramadi BK; Jelonek MT; Boyd LF; Margulies DH; Bothwell AL
    J Immunol; 1995 Jul; 155(2):662-73. PubMed ID: 7541822
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Accumulation of serial forces on TCR and CD8 frequently applied by agonist antigenic peptides embedded in MHC molecules triggers calcium in T cells.
    Pryshchep S; Zarnitsyna VI; Hong J; Evavold BD; Zhu C
    J Immunol; 2014 Jul; 193(1):68-76. PubMed ID: 24890718
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of the expression of peptide-major histocompatibility complexes using high affinity soluble divalent T cell receptors.
    O'Herrin SM; Lebowitz MS; Bieler JG; al-Ramadi BK; Utz U; Bothwell AL; Schneck JP
    J Exp Med; 1997 Oct; 186(8):1333-45. PubMed ID: 9334373
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ribosylation of the CD8αβ heterodimer permits binding of the nonclassical major histocompatibility molecule, H2-Q10.
    Goodall KJ; Nguyen A; Andrews DM; Sullivan LC
    J Biol Chem; 2021 Oct; 297(4):101141. PubMed ID: 34478713
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD8+ memory T cells (CD44high, Ly-6C+) are more sensitive than naive cells to (CD44low, Ly-6C-) to TCR/CD8 signaling in response to antigen.
    Curtsinger JM; Lins DC; Mescher MF
    J Immunol; 1998 Apr; 160(7):3236-43. PubMed ID: 9531279
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interplay between the TCR/CD3 complex and CD4 or CD8 in the activation of cytotoxic T lymphocytes.
    de Vries JE; Yssel H; Spits H
    Immunol Rev; 1989 Jun; 109():119-41. PubMed ID: 2527803
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The human CD8 coreceptor effects cytotoxic T cell activation and antigen sensitivity primarily by mediating complete phosphorylation of the T cell receptor zeta chain.
    Purbhoo MA; Boulter JM; Price DA; Vuidepot AL; Hourigan CS; Dunbar PR; Olson K; Dawson SJ; Phillips RE; Jakobsen BK; Bell JI; Sewell AK
    J Biol Chem; 2001 Aug; 276(35):32786-92. PubMed ID: 11438524
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interactions between MHC molecules and co-receptors of the TCR.
    König R
    Curr Opin Immunol; 2002 Feb; 14(1):75-83. PubMed ID: 11790535
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Xenogeneic beta 2-microglobulin substitution affects functional binding of MHC class I molecules by CD8+ T cells.
    Benoit LA; Tan R
    J Immunol; 2007 Sep; 179(6):3588-95. PubMed ID: 17785793
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peripheral "CD8 tuning" dynamically modulates the size and responsiveness of an antigen-specific T cell pool in vivo.
    Maile R; Siler CA; Kerry SE; Midkiff KE; Collins EJ; Frelinger JA
    J Immunol; 2005 Jan; 174(2):619-27. PubMed ID: 15634879
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The efficiency of CD4 recruitment to ligand-engaged TCR controls the agonist/partial agonist properties of peptide-MHC molecule ligands.
    Madrenas J; Chau LA; Smith J; Bluestone JA; Germain RN
    J Exp Med; 1997 Jan; 185(2):219-29. PubMed ID: 9016871
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High affinity xenoreactive TCR:MHC interaction recruits CD8 in absence of binding to MHC.
    Buslepp J; Kerry SE; Loftus D; Frelinger JA; Appella E; Collins EJ
    J Immunol; 2003 Jan; 170(1):373-83. PubMed ID: 12496422
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of CD8-MHC class I interaction in detection and sorting efficiencies of antigen-specific T cells using MHC class I/peptide multimers: contribution of pMHC valency.
    Neveu B; Echasserieau K; Hill T; Kuus-Reichel K; Houssaint E; Bonneville M; Saulquin X
    Int Immunol; 2006 Jul; 18(7):1139-45. PubMed ID: 16751231
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-affinity reactions between antigen-specific T-cell receptors and peptides associated with allogeneic and syngeneic major histocompatibility complex class I proteins.
    Sykulev Y; Brunmark A; Tsomides TJ; Kageyama S; Jackson M; Peterson PA; Eisen HN
    Proc Natl Acad Sci U S A; 1994 Nov; 91(24):11487-91. PubMed ID: 7972089
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Generation of antigen specific CD8+ cytotoxic T cells following immunization with soluble protein formulated with novel glycoside adjuvants.
    Sheikh NA; Rajananthanan P; Attard GS; Morrow WJ
    Vaccine; 1999 Aug; 17(23-24):2974-82. PubMed ID: 10462232
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.